Streetbeat News

Earnings

BTAI

BioXcel Therapeutics (NASDAQ:BTAI) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-1.72. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $7.39, down 52.82% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

LICY

Li-Cycle Holdings (NYSE:LICY) is set to release its latest quarterly earnings report on Monday, 2023-08-14. Analysts estimate an earnings per share (EPS) of $-0.20. The company's past performance shows a pattern of share price changes following earnings reports. Shares of Li-Cycle Holdings were trading at $5.61 as of August 10, with a 52-week period decline of 30.72%.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

DOYU

DouYu Intl Hldgs (NASDAQ:DOYU) is set to release its latest quarterly earnings report on Monday, 2023-08-14. Analysts estimate an earnings per share (EPS) of $0.02. The company's past performance shows a mixed impact on the share price post-earnings release. The shares were trading at $1.08 as of August 10, with a 52-week return of -22.43%.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

HUMA

Humacyte (NASDAQ:HUMA) is set to release its latest quarterly earnings report on Monday, 2023-08-14. Analysts estimate an earnings per share (EPS) of $-0.22. The company's past performance shows a trend of missing EPS estimates, which has generally led to a drop in share price. Shares of Humacyte were trading at $3.41 as of August 10, with a 52-week drop of 29.92%.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

BCLI

Brainstorm Cell (NASDAQ:BCLI) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.15. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $1.62, down 53.3% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

MNDY

Monday.Com (NASDAQ:MNDY) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $0.14. The company's past performance shows a pattern of beating EPS estimates, but this has not always led to a rise in share price. The stock is currently trading at $155.32 and has seen a 13.77% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

ERJ

Embraer (NYSE:ERJ) is set to release its quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $0.12. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varying impacts on the share price. Embraer's shares were trading at $14.76 as of August 10, with a 26.16% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:00 pm

GME

WE

WeWork Inc's stock gained over 35% on Friday, triggering speculation of it becoming the latest meme stock like GameStop. The r/WallStreetBets community is rallying behind the stock. WeWork reported dismal Q2 financial results this week, with a loss of 21 cents per share and revenues of $844.00 million, both missing consensus estimates. The session volume crossed the 63 million mark vs. the average 100-day volume of 34 million.

Portfolio Pulse from Anusuya Lahiri

August 11, 2023 | 1:51 pm

AMRS

CANO

JYNT

TSAT

WE

YTEN

U.S. stocks traded lower following the release of PPI data, with the NASDAQ falling 0.84%. Producer prices in the U.S. increased 0.3% month-over-month in July, the biggest rise since January. Amyris, Inc. (AMRS) shares shot up 97% after filing for Chapter 11 bankruptcy. Telesat Corporation (TSAT) shares rose 48% after reporting Q2 results and a $2.1 billion deal with MDA. WeWork Inc. (WE) shares gained 43% despite doubts over its ability to stay in business. Yield10 Bioscience, Inc. (YTEN) shares dropped 58% after announcing a $3.7 million public offering. Cano Health, Inc. (CANO) shares were down 59% after reporting worse-than-expected Q2 results and expressing doubt over its ability to continue as a going concern. The Joint Corp. (JYNT) shares fell 26% after reporting Q2 operating highlights.

Portfolio Pulse from Lisa Levin

August 11, 2023 | 1:48 pm

MAR

Marriott International's Q2 earnings surpassed analyst predictions, with earnings per share of $2.26 and a quarterly revenue of $6.1 billion. The company has consistently exceeded market expectations since Q3 of June 2020, with its stock price surging by 142% over the past year. Despite significant fluctuations in 2022, the stock made a comeback, surpassing the $200 mark in July 2023.

Portfolio Pulse from Zaheer Anwari

August 11, 2023 | 1:33 pm